Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Hikma Opens Discussions To Acquire GSK Businesses In Egypt And Tunisia

Deal Would Include Hikma Acquiring GSK’s 91.2% Holding

26 Jan 2021

• By Dean Rudge

Earth — Hikma already has a significant presence in the MENA region, striking several licensing deals in 2020. • Source: Shutterstock

Related Content

Hikma Suspends Roll-Out Of Advair Rival

18 Jan 2021

Hikma Enjoys Luxury Of M&A Opportunism

16 Apr 2020

Hikma Is Keeping On Top Of COVID ‘Rollercoaster’

09 Sep 2020

Hikma’s First-Half Profits Leap By A Quarter

11 Aug 2020

Hikma Set To Buy Back £295m In Shares

03 Jul 2020

Sun And Hikma Strike Ilumya Deal

18 Jun 2020

Hikma Adds Sesen’s Vicineum To MENA Brands

04 Dec 2020

Related Companies

Hikma Pharmaceuticals plc

Additional Topics

Middle East and Africa Egypt Tunisia Deals M & A Strategy BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.